Characterisation of the cytokine response in the Acute Coronary Syndrome and its modulation with angiotensin-converting enzyme inhibition (Protocol B)

Completed

• Conditions: Acute coronary syndrome; Circulatory System; Other acute ischaemic heart diseases

• Registration Number: ISRCTN51684951
• Lead Sponsor: Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

The patient population will be drawn from all patients admitted to the cardiac unit based at the Leeds General Infirmary or St James's University Hospital with chest pain within the preceding 24 h. Patients must have a history and electrocardiogram (ECG) changes consistent with a diagnosis of the Acute Coronary Syndrome.

Exclusion Criteria

Patients with ST elevation myocardial infarction

Study & Design

• Study Type: Interventional
• Study Design: Not specified